Label-free, automated classification of microsatellite status in colorectal cancer by infrared imaging

• Published in: Scientific reports 2020-06, Vol.10 (1), p.10161-10161, Article 10161
• Main Authors: Kallenbach-Thieltges, Angela, Großerueschkamp, Frederik, Jütte, Hendrik, Kuepper, Claus, Reinacher-Schick, Anke, Tannapfel, Andrea, Gerwert, Klaus
• Format: Article
• Language: English
• Subjects: 631/67/1504/1885; 631/67/2321; 692/699/67/1504/1885; 692/699/67/2321; 96/63; Cancer; Colorectal cancer; Colorectal carcinoma; Colorectal Neoplasms - diagnostic imaging; Colorectal Neoplasms - etiology; Colorectal Neoplasms - genetics; Colorectal Neoplasms - pathology; DNA Mismatch Repair; Feasibility Studies; Humanities and Social Sciences; Humans; Immunohistochemistry; Immunohistochemistry - methods; Infrared imaging; Infrared Rays; Lasers, Semiconductor; Microsatellite Instability; Mismatch repair; multidisciplinary; Neoplasm Staging; Science; Science (multidisciplinary); Spectroscopy, Fourier Transform Infrared - methods
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-020-67052-z

Challenging histopathological diagnostics in cancer include microsatellite instability-high (MSI-H) colorectal cancer (CRC), which occurs in 15% of early-stage CRC and is caused by a deficiency in the mismatch repair system. The diagnosis of MSI-H cannot be reliably achieved by visual inspection of a hematoxylin and eosin stained thin section alone, but additionally requires subsequent molecular analysis. Time- and sample-intensive immunohistochemistry with subsequent fragment length analysis is used. The aim of the presented feasibility study is to test the ability of quantum cascade laser (QCL)-based infrared (IR) imaging as an alternative diagnostic tool for MSI-H in CRC. We analyzed samples from 100 patients with sporadic CRC UICC stage II and III. Forty samples were used to develop the random forest classifier and 60 samples to verify the results on an independent blinded dataset. Specifically, 100% sensitivity and 93% specificity were achieved based on the independent 30 MSI-H- and 30 microsatellite stable (MSS)-patient validation cohort. This showed that QCL-based IR imaging is able to distinguish between MSI-H and MSS for sporadic CRC - a question that goes beyond morphological features - based on the use of spatially resolved infrared spectra used as biomolecular fingerprints.